BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 27546618)

  • 1. Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.
    Tominaga K; Shimamura T; Kimura N; Murayama T; Matsubara D; Kanauchi H; Niida A; Shimizu S; Nishioka K; Tsuji EI; Yano M; Sugano S; Shimono Y; Ishii H; Saya H; Mori M; Akashi K; Tada KI; Ogawa T; Tojo A; Miyano S; Gotoh N
    Oncogene; 2017 Mar; 36(9):1276-1286. PubMed ID: 27546618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation.
    Glinka Y; Mohammed N; Subramaniam V; Jothy S; Prud'homme GJ
    Biochem Biophys Res Commun; 2012 Sep; 425(4):775-80. PubMed ID: 22885184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness.
    Xu WW; Li B; Zhao JF; Yang JG; Li JQ; Tsao SW; He QY; Cheung ALM
    Cancer Lett; 2018 Jul; 425():88-100. PubMed ID: 29604392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
    Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
    J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance.
    Li B; Xu WW; Guan XY; Qin YR; Law S; Lee NP; Chan KT; Tam PY; Li YY; Chan KW; Yuen HF; Tsao SW; He QY; Cheung AL
    Clin Cancer Res; 2016 Mar; 22(5):1243-55. PubMed ID: 26475334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells.
    Pacher M; Seewald MJ; Mikula M; Oehler S; Mogg M; Vinatzer U; Eger A; Schweifer N; Varecka R; Sommergruber W; Mikulits W; Schreiber M
    Carcinogenesis; 2007 Jan; 28(1):49-59. PubMed ID: 16774935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M2‑like tumour‑associated macrophage‑secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway.
    Lv J; Liu C; Chen FK; Feng ZP; Jia L; Liu PJ; Yang ZX; Hou F; Deng ZY
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
    Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
    Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Id1-induced IGF-II and its autocrine/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy.
    Li B; Tsao SW; Chan KW; Ludwig DL; Novosyadlyy R; Li YY; He QY; Cheung AL
    Clin Cancer Res; 2014 May; 20(10):2651-62. PubMed ID: 24599933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
    Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy.
    Jin X; Jin X; Kim LJY; Dixit D; Jeon HY; Kim EJ; Kim JK; Lee SY; Yin J; Rich JN; Kim H
    Clin Cancer Res; 2018 Jan; 24(2):383-394. PubMed ID: 29208670
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression.
    Xu WW; Li B; Guan XY; Chung SK; Wang Y; Yip YL; Law SY; Chan KT; Lee NP; Chan KW; Xu LY; Li EM; Tsao SW; He QY; Cheung AL
    Nat Commun; 2017 Feb; 8():14399. PubMed ID: 28186102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of down-regulation of IGF2 gene on the biological characteristics of HCT116 colon cancer stem cells].
    Zhao X; Li J; Liu HQ; Liu XL
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):580-586. PubMed ID: 31434448
    [No Abstract]   [Full Text] [Related]  

  • 15. Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell-like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine Circuit.
    Murayama T; Nakaoku T; Enari M; Nishimura T; Tominaga K; Nakata A; Tojo A; Sugano S; Kohno T; Gotoh N
    Cancer Res; 2016 Feb; 76(4):974-83. PubMed ID: 26837769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.
    Vennin C; Spruyt N; Robin YM; Chassat T; Le Bourhis X; Adriaenssens E
    Cancer Lett; 2017 Jan; 385():198-206. PubMed ID: 27780718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties.
    Manrique I; Nguewa P; Bleau AM; Nistal-Villan E; Lopez I; Villalba M; Gil-Bazo I; Calvo A
    Cancer Lett; 2015 Jan; 356(2 Pt B):899-909. PubMed ID: 25449776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.
    Storci G; Sansone P; Mari S; D'Uva G; Tavolari S; Guarnieri T; Taffurelli M; Ceccarelli C; Santini D; Chieco P; Marcu KB; Bonafè M
    J Cell Physiol; 2010 Nov; 225(3):682-91. PubMed ID: 20509143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells.
    Li J; Condello S; Thomes-Pepin J; Ma X; Xia Y; Hurley TD; Matei D; Cheng JX
    Cell Stem Cell; 2017 Mar; 20(3):303-314.e5. PubMed ID: 28041894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.